Literature DB >> 10606975

Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

R Schubert1, J Reichenbach, N Royer, M Pichler, S Zielen.   

Abstract

T cell lymphopenia in the peripheral blood lymphocytes (PBL) of patients with AT is mainly caused by a decrease of naive CD45RA+/CD4+ cells followed by a predominance of memory CD45RO+ lymphocytes. To relate these findings to the regulation of programmed cell death, we investigated the activation state and apoptotic level of PBL in 12 patients and healthy controls by flow cytometry. In accordance with previous investigations, the number of naive CD4+/CD45RA+ cells was significantly decreased in patients compared with healthy controls. This disturbed balance of CD45RA and CD45RO was also reflected in higher amounts of activated HLA-DR and CD95 expressing cells, with a concomitant decrease of Bcl-2 protected lymphocytes in the T cell population. With regard to its role in preventing oxidative-induced cell death, we analysed Bcl-2 expression and apoptosis in the presence of oxidative stress. In culture, cells of patients are more susceptible to spontaneous programmed cell death. However, in our stress-inducing system (hypoxanthine/xanthine oxidase system) the number of cells undergoing apoptosis was lower in patients' cell populations compared with controls. In addition, preliminary results suggest that Bcl-2 expression and level of spontaneous apoptosis in patients can be modified by IL-2 and interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606975      PMCID: PMC1905521          DOI: 10.1046/j.1365-2249.2000.01098.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Interconversion of CD45R subsets of CD4 T cells in vivo.

Authors:  E B Bell; S M Sparshott
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

2.  Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage.

Authors:  C Cherbonnel-Lasserre; M K Dosanjh
Journal:  Biochimie       Date:  1997-10       Impact factor: 4.079

3.  Response of fibroblast cultures from ataxia-telangiectasia patients to oxidative stress.

Authors:  M Yi; M P Rosin; C K Anderson
Journal:  Cancer Lett       Date:  1990-10-08       Impact factor: 8.679

4.  Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity.

Authors:  E Duchaud; A Ridet; D Stoppa-Lyonnet; N Janin; E Moustacchi; F Rosselli
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

5.  B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis.

Authors:  A Saxon; B Keld; D Diaz-Sanchez; B C Guo; N Sidell
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia.

Authors:  T A Waldmann; S Broder; C K Goldman; K Frost; S J Korsmeyer; M A Medici
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

Review 7.  Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?

Authors:  G Rotman; Y Shiloh
Journal:  Bioessays       Date:  1997-10       Impact factor: 4.345

Review 8.  Ataxia-telangiectasia and cellular responses to DNA damage.

Authors:  M S Meyn
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

9.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

10.  Differential regulation of bcl-2, bax, c-fos, junB, and krox-24 expression in the cerebellum of Purkinje cell degeneration mutant mice.

Authors:  F Gillardon; J Bäurle; H Wickert; U Grüsser-Cornehls; M Zimmermann
Journal:  J Neurosci Res       Date:  1995-08-01       Impact factor: 4.164

View more
  5 in total

1.  Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia.

Authors:  J Reichenbach; R Schubert; J Feinberg; O Beck; M Rosewich; M A Rose; S Zielen
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 2.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

3.  Ataxia telangiectasia alters the ApoB and reelin pathway.

Authors:  Júlia Canet-Pons; Ralf Schubert; Ruth Pia Duecker; Roland Schrewe; Sandra Wölke; Matthias Kieslich; Martina Schnölzer; Andreas Chiocchetti; Georg Auburger; Stefan Zielen; Uwe Warnken
Journal:  Neurogenetics       Date:  2018-10-21       Impact factor: 2.660

4.  Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis.

Authors:  C J Harbort; Paulo Vitor Soeiro-Pereira; Horst von Bernuth; Angela M Kaindl; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Janine Reichenbach; Joachim Roesler; Arturo Zychlinsky; Borko Amulic
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

Review 5.  DNA damage: a sensible mediator of the differentiation decision in hematopoietic stem cells and in leukemia.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Int J Mol Sci       Date:  2015-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.